Macro‐and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Y Shi, PM Vanhoutte - Journal of diabetes, 2017 - Wiley Online Library
血管内皮细胞和内皮细胞释放的活性因子是调控血管舒张功能的重要因素. 糖尿病是慢性心血管
疾病的高危因素之一. 目前认为高糖和糖尿病引起的内皮细胞功能障碍是造成血管功能改变 …
疾病的高危因素之一. 目前认为高糖和糖尿病引起的内皮细胞功能障碍是造成血管功能改变 …
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
MA Incalza, R D'Oria, A Natalicchio, S Perrini… - Vascular …, 2018 - Elsevier
Reactive oxygen species (ROS) are reactive intermediates of molecular oxygen that act as
important second messengers within the cells; however, an imbalance between generation …
important second messengers within the cells; however, an imbalance between generation …
Glycaemic management in diabetes: old and new approaches
HbA 1c is the most used parameter to assess glycaemic control. However, evidence
suggests that the concept of hyperglycaemia has profoundly changed and that different …
suggests that the concept of hyperglycaemia has profoundly changed and that different …
Prevention of diabetes and cardiovascular disease in obesity
L La Sala, AE Pontiroli - International journal of molecular sciences, 2020 - mdpi.com
Obesity is one of the major risk factors for the development of both impaired glucose
tolerance (IGT, or prediabetes) and type 2 diabetes (T2D), and its prevalence worldwide …
tolerance (IGT, or prediabetes) and type 2 diabetes (T2D), and its prevalence worldwide …
The link between diabetes and atherosclerosis
L La Sala, F Prattichizzo… - European journal of …, 2019 - journals.sagepub.com
Atherosclerosis is one of the main complications of diabetes involving multiple causative
factors. Dysfunction of the vascular endothelium is a hallmark of most conditions that are …
factors. Dysfunction of the vascular endothelium is a hallmark of most conditions that are …
Glucose variability: how does it work?
A growing body of evidence points to the role of glucose variability (GV) in the development
of the microvascular and macrovascular complications of diabetes. In this review, we …
of the microvascular and macrovascular complications of diabetes. In this review, we …
Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links
S De Rosa, B Arcidiacono, E Chiefari… - Frontiers in …, 2018 - frontiersin.org
Type 2 diabetes mellitus (DM) is a common metabolic disorder predisposing to diabetic
cardiomyopathy and atherosclerotic cardiovascular disease (CVD), which could lead to …
cardiomyopathy and atherosclerotic cardiovascular disease (CVD), which could lead to …
Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes
P Yang, J Feng, Q Peng, X Liu… - Oxidative Medicine and …, 2019 - Wiley Online Library
The occurrence and development of cardiovascular complications are predominantly
responsible for the increased morbidity and mortality observed in patients with diabetes …
responsible for the increased morbidity and mortality observed in patients with diabetes …
[HTML][HTML] MicroRNAs in the regulation of cellular redox status and its implications in myocardial ischemia-reperfusion injury
T Carbonell, AV Gomes - Redox biology, 2020 - Elsevier
MicroRNAs (miRNAs) are small RNAs that do not encode for proteins and play key roles in
the regulation of gene expression. miRNAs are involved in a comprehensive range of …
the regulation of gene expression. miRNAs are involved in a comprehensive range of …
A unique plasma microRNA profile defines type 2 diabetes progression
A major unmet medical need to better manage Type 2 Diabetes (T2D) is the accurate
disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed …
disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed …